5C59.01

ICD-11 MMS 2026-01

Disorders of pterin metabolism

Description

Any condition caused by failure to correctly metabolize pterin.

Index terms

  • Disorders of pterin metabolism
  • Malignant hyperphenylalaninaemia due to tetrahydrobiopterin deficiency
  • Malignant hyperphenylalaninaemia due to BH4 deficiency
Show allHide
  • Dihydropteridine reductase deficiency
  • DHPR - [Dihydropteridine reductase] deficiency
  • 6-pyruvoyl-tetrahydropterin synthase deficiency
  • PTPS - [6-pyruvoyl-tetrahydropterin synthase] deficiency
  • GTP cyclohydrolase 1 deficiency
  • GTPCH deficiency
  • Guanosine-5-triphosphatase cyclohydrolase deficiency
  • Hyperphenylalaninaemia due to GTP cyclohydrolase deficiency
  • Hyperphenylalaninaemia with neopterin deficiency
  • Pterin-4-carbinolamine dehydratase deficiency
  • Dehydratase deficiency
  • Hyperphenylalaninaemia due to dehydratase deficiency
  • Hyperphenylalaninaemia due to pterin-4-alpha-carbinolamine dehydratase deficiency
  • Primapterinuria
  • Motor or cognitive disorder due to sepiapterin reductase deficiency

Exclusions from above levels

  • http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
  • 3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency
  • 5A71.01 – Congenital adrenal hyperplasia
Show allHide
  • 5A81.1 – 5-alpha-reductase deficiency
  • LD28.01 – Marfan syndrome
  • LD28.1 – Ehlers-Danlos syndrome
  • LD2A.4 – androgen resistance syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

  • 5C59.00 – Disorders of catecholamine synthesis
  • 5C59.0Y – Other specified disorders of biogenic amine metabolism
  • 5C59.0Z – Disorders of biogenic amine metabolism, unspecified

Foundation entity

Disorders of pterin metabolism – http://id.who.int/icd/entity/1801446733

Part of: 5C59.0: Disorders of biogenic amine metabolism › 5C59: Inborn errors of neurotransmitter metabolism › 05: Endocrine, nutritional or metabolic diseases